Immunotherapy of allergy: anergy, deletion, and immune deviation
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 10 (6) , 640-645
- https://doi.org/10.1016/s0952-7915(98)80082-4
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Induction of Tolerance via the Respiratory MucosaInternational Archives of Allergy and Immunology, 1998
- Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1–specific human T-cell clonesJournal of Allergy and Clinical Immunology, 1998
- Effects of peptide therapy on ex vivo T-cell responsesJournal of Allergy and Clinical Immunology, 1998
- Recombinant allergens for immunotherapy: A Der p 2 variant with reduced IgE reactivity retains T-cell epitopes☆☆☆★★★Journal of Allergy and Clinical Immunology, 1998
- Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: a role for intramolecular epitope suppressionInternational Immunology, 1997
- Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-γ production in CD4+ T cellsJournal of Allergy and Clinical Immunology, 1997
- Allergen-driven limiting dilution analysis of human IL-4 and IFN-γ production in allergic rhinitis and clinically tolerant individualszInternational Immunology, 1996
- T cell response to grass pollen allergens: Correlation with skin test reactivity and serum IgE levelsImmunology & Cell Biology, 1995
- The Specificity and Regulation of T-Cell Responsiveness to AllergensAnnual Review of Immunology, 1991
- Generation of Antigen-Specific Suppressor Cells during Allergy DesensitizationNew England Journal of Medicine, 1980